← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2013Last known activity
Oct 25, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT03279289Study chairPhase 2Oct 25, 2017
- NCT02929888Overall official - principal investigatorPhase 2/Phase 3Oct 1, 2016
- NCT02243137Overall official - principal investigatorPhase 1May 1, 2013
Details
- Last known activity
- Oct 25, 2017